Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



local anesthesia1 - prostate cancer care1 - erythrocyte casts1 - cardiac death1 - mild kidney disease1 - kidney injury risk1 - prepucial stones1 - the american society of nephrology3 - heart surgery2 - x-ray1 - biopsy for prostate cancer1 - nephrons2 - renal carcinoma1 - focused ultrasound surgery foundation1 - concentrated urine1 - irregular heart rhythm1 - androgen-deprivation therapy1 - stones etiology3 - calcium-rich foods1 - risk of diabetes1 - kidney disease complications1 - nephrocalcinosis3 - intermittent urinary stream1 - urinary function1 - bladder control loss1 - skeletal complication1 - american society of clinical oncology1 - prostate cancers1 - progression-free survival1 - urinary ph1 -